Epidemiology of medication-related adverse events in nursing homes
References (46)
- et al.
Medication error reporting in long term care
Am J Geriatr Pharmacother.
(2004) Medication errors and adverse drug events in nursing homes: Problems, causes, regulations, and proposed solutions
J Am Med Dir Assoc
(2001)- et al.
Incidence and preventability of adverse drug events in nursing homes
Am J Med.
(2000) - et al.
The incidence of adverse drug events in two large academic long-term care facilities
Am J Med.
(2005) - et al.
Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents
Am J Geriatr Pharmacother.
(2006) How many deaths occur annually from adverse drug reactions in the United States?
Am J Med.
(2000)- et al.
Characteristics of the SAGE database: A new resource for research on outcomes in long-term care
J Gerontol A Biol Sci Med Sci.
(1999) - et al.
Drug use in the nursing home
Ann Intern Med.
(1995) - et al.
The pharmacology of aging
- et al.
National estimates of medication use in nursing homes: Findings from the 1997 Medicare current beneficiary survey and the 1996 medical expenditure survey
J Am Geriatr Soc.
(2005)
Preventing Medication Errors
(2006)
Medication errors observed in 36 health care facilities
Arch Intern Med.
(2002)
Medication errors in nursing homes: Part II. Surveyor methodology for detecting medication errors
Nurs Houles
(1985)
Medication errors in nursing homes: Part I
Nurs Homes
(1985)
Problem-based geriatric medicine
Clarification of terminology in drug safety
Drug Saf.
(2005)
Adverse drug reactions
Drug-associated hospital admissions in older medical patients
J Am Geriatr Soc.
(1988)
The health care cost of drug-related morbidity and mortality in nursing facilities
Arch Intern Med.
(1997)
Epidemiology of adverse drug events in the nursing home setting
Drugs Aging
(1995)
Epidemiology of adverse drug reactions in the elderly by drug class
Drugs Aging
(1999)
Identification of elderly nursing facility residents at high risk for drugrelated problems
Consult Pharm
(1997)
Information is care: The need for data to assess the quality of care in UK nursing and residential homes
Expert Opin Drug Saf.
(2003)
Cited by (134)
Systematic Review of Psychotropic Adverse Drug Event Monitoring Tools for Use in Long-Term Care Facilities
2023, Journal of the American Medical Directors AssociationA work system analysis of the medication administration process in a Norwegian nursing home ward
2020, Applied ErgonomicsCitation Excerpt :Nursing home patients often have multiple diagnoses and a high prevalence of polypharmacy and are therefore at high risk of being subjected to adverse drug events (ADE) (Herr et al., 2017). This may result in additional monitoring, interventions, hospitalisation or death (Handler et al., 2006). Nursing homes vary greatly in terms of demographics, patients, staff, regulations and norms.
Clinical Pharmacy Considerations in Special Populations: Geriatrics
2019, Encyclopedia of Pharmacy Practice and Clinical Pharmacy: Volumes 1-3Clinical pharmacy considerations in special populations: Geriatrics
2019, Encyclopedia of Pharmacy Practice and Clinical PharmacyA pragmatic approach to iatrogenic risk in the emergency room
2021, Soins Gerontologie
Copyright © 2006 Published by Elsevier Inc.